LWAY

Business Context and Reporting Period

Company: Lifeway Foods, Inc. (LWAY)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Lifeway is the largest producer and marketer of kefir in the U.S., operating as a single reportable segment. The company manufactures and markets drinkable kefir, European-style soft cheeses, cream, drinkable yogurt, and other dairy products under the Lifeway, Fresh Made, and GlenOaks Farms brands. Operations are primarily based in the United States with facilities in Illinois, Wisconsin, and Pennsylvania.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 13.7% to $212.5 million, driven primarily by higher volumes of branded drinkable kefir. On a comparable basis (adjusting for a strategic customer exit and a distributor logistics shift in 2024), sales increased approximately 19%.
• Margin Expansion: Gross margin improved to 27.4% from 26.0%, attributed to manufacturing efficiencies from higher volumes and favorable conventional milk pricing.
• Expense Increases: Selling expenses rose 35% to $19.9 million due to increased marketing investments. General and administrative expenses increased 11% to $21.6 million, largely due to $6.2 million in legal and professional fees related to Danone's unsolicited purchase proposal and stockholder actions.
• Investing Activity: Cash used in investing activities surged to $22.0 million (from $6.7 million) due to significant capital expenditures ($27.4 million) for the expansion and modernization of the Waukesha, Wisconsin facility. This was partially offset by $5.2 million in proceeds from the sale of the Simple Mills investment.
• Debt Facility: The revolving credit facility commitment was increased from $5 million to $25 million in February 2025, with the maturity extended to 2029. No borrowings were outstanding as of year-end.

Guidance, Outlook, and Risks

• Strategic Developments: In September 2025, the Company entered a Cooperation Agreement with Danone, resulting in a refreshed Board of Directors with four new independent directors. Pending litigation regarding the Stockholders' Agreement was stayed.
• Capital Projects: The Waukesha facility expansion is expected to double manufacturing capacity and improve packaging efficiency. The project is estimated to cost approximately $48 million and is expected to be completed in Q4 2026.
• Supply Chain Strategy: To secure organic milk supply, the Company purchased 799 mature dairy cows for $2.9 million and entered a five-year "Herd Agreement" with a third-party dairy facility.
• Key Risks:
  • Competition: Intense competition from established dairy brands (e.g., Danone, Chobani) and private labels, as well as non-dairy probiotic products.
  • Input Costs: Volatility in milk prices and other raw materials could impact gross margins.
  • Corporate Governance: Concentration of ownership among the Smolyansky family, Danone, and Divisadero Street Partners could influence corporate decisions. A Shareholder Rights Plan (poison pill) remains in effect until October 2026.
  • Customer Concentration: Two customers accounted for 24% of net sales in 2025.

Investor Verification Checklist

• Verify the timeline and completion status of the $48 million Waukesha facility expansion and its impact on future capacity.
• Monitor the status of the Cooperation Agreement with Danone and any potential changes in corporate control or board composition.
• Assess the sustainability of gross margin improvements given historical volatility in milk commodity prices.
• Review the impact of the $6.2 million in one-time legal fees on future G&A expense baselines.
• Confirm the execution of the organic milk supply strategy via the new Herd Agreement.